
1 / 6GLP Peptides · Popular Peptides
$312.00$156.00Save 50%
Cagrilintide (also referenced as AM833) is a long-acting synthetic amylin analogue — a peptide modeled on amylin, the pancreatic hormone co-secreted with insulin — studied in vitro and in animal models as an amylin and calcitonin receptor agonist within metabolic and satiety-signaling research.
Real Peptides supplies Cagrilintide as a lyophilized 10mg vial for research use only. Every batch is submitted to an independent analytical laboratory, and the certificate of analysis for the current lot is published on the lab results page so identity and purity can be reviewed before purchase. Orders ship from facilities in Florida and California within 24 hours. This material is not a drug, supplement or cosmetic and is not intended for human or veterinary use.
Quantity
$156.00
Cagrilintide · 10mg
$156.00$312.00
For Research Use Only. Not for human consumption or therapeutic treatment.
Cagrilintide is a powerful, long-acting analogue of the naturally secreted hormone amylin—co-released with insulin. Designed to probe appetite control, glycemic balance, and fat-metabolism in lab models, Cagrilintide slows gastric emptying, modulates satiety pathways, and drives body-fat reduction in rodent and primate studies. When paired with GLP-1 agonists like semaglutide or retatrutide, it delivers amplified metabolic effects. Each 10 mg vial is HPLC-tested to ≥99% purity, endotoxin-screened (<0.1 EU/mg), and shipped with a Certificate of Analysis—perfect for high-integrity obesity, diabetes, and NAFLD research.



GLP Peptides compounds